The sales of antibacterial medicine in Germany have demonstrated a consistent downward trend from 2013 to 2021, with sales declining from 2.6 units to 1 unit in 2021. This represents a significant cumulative decrease. From 2013 to 2017, the year-on-year decrease was generally moderate, ranging from around 4% to 5%. However, the decline accelerated from 2018 to 2021, with double-digit year-on-year drops including a notable 20% in 2020 and 16.67% in 2021. The December of 2022 showed a recovery with a growth of 30% followed by stable sales in 2023.
In 2023, the total sales of antibacterial medicine stood at 1.3 units. Looking at the forecast period from 2024 to 2028, sales are projected to continue to decline but at a slower pace, with an expected average annual decrease (CAGR) of 3.29%, leading to a forecasted value of 1.1 units in 2028.
Future trends to watch for:
- Shifts in regulatory frameworks and policies affecting antibiotic prescriptions.
- Developments in alternative treatments for bacterial infections.
- Trends in antibiotic resistance influencing demand and sales.
- Public health campaigns impacting consumer behavior relative to antibiotic use.
